Showing 1,481 - 1,500 results of 118,670 for search '(( i mean decrease ) OR ( 5 ((step decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 1.79s Refine Results
  1. 1481
  2. 1482
  3. 1483

    Expression of pro-fibrotic genes of the TGFβ family is substantially decreased following AT1 receptor antagonism. by Anne-Cécile Huby (5653777)

    Published 2013
    “…Note that the increased expression of pro-fibrotic genes in RenTg mice was decreased to normal levels following treatment with the AT1 receptor antagonist. …”
  4. 1484
  5. 1485
  6. 1486
  7. 1487
  8. 1488
  9. 1489
  10. 1490
  11. 1491
  12. 1492
  13. 1493

    UVB irradiation decreased TM expression in HaCaT cells. by Huey-Chun Huang (429098)

    Published 2013
    “…<p>(A) HaCaT Cells were exposed to UVB irradiation in a dose-response (0, 1.5, 3, 4.5, 6 mJ/cm<sup>2</sup>) Cell viability was examined by trypan blue exclusion. …”
  14. 1494
  15. 1495
  16. 1496

    The rate of lariat formation is decreased two-fold by isoginkgetin treatment. by Jesse M. Gray (527662)

    Published 2014
    “…(<b>B</b>) Isoginkgetin treatment increases the “guillotine” base height (<i>p</i> = 10<sup>−12</sup>) of intronic expression without increasing the blade height (<i>p</i> = 0.5), consistent with a splicing defect (compare to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089673#pone-0089673-g001" target="_blank">Fig. 1A</a>). …”
  17. 1497
  18. 1498

    Damage accumulation decreases elongation rates and displaces growth equilibrium. by Audrey Menegaz Proenca (845486)

    Published 2019
    “…<p>All panels depict MG1655 wild-type <i>E</i>. <i>coli</i>. (A) Exposure to phototoxic damage led to decreasing elongation rates in all treatment levels (length of exposure, every 2 min: 70 ms, 700 ms, 1 s, 1.5 s, 3 s). …”
  19. 1499
  20. 1500

    CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

    Published 2014
    “…Immortalized HBECs with (A) lenti-<i>KRas</i><sup>V12</sup>, (B) lenti-<i>KRas</i><sup>V12</sup> and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i><sup>V12</sup>, sh<i>p53</i>, and <i>myc</i> overexpression. …”